Navigation Links
Summit Yields One-of-a-Kind Opportunity To Reduce Prescription Drug Overdoses
Date:11/16/2012

NEWARK, Del., Nov. 16, 2012 /PRNewswire-USNewswire/ --Today, a not-for-profit organization presenting at the Delaware Prescription Drug Abuse Summit appealed to the event's host, Attorney General Beau Biden, for assistance in preventing medication overdoses.  The Center for Lawful Access and Abuse Deterrence (CLAAD) asked Biden to work closely with his father, Vice President Joe Biden, to ensure that federal regulators properly implement Obama-Biden Administration drug policies. 

During CLAAD's presentation at the summit, Director Michael Barnes warned that pain medications without added safety features could flood back into communities in the coming weeks if the Food and Drug Administration (FDA) fails to follow the Obama-Biden strategy.

In recent years, the makers of the opioid pain relievers OxyContin and Opana removed their traditional products from the market in favor of new versions designed to impede certain forms of intentional abuse.  Preliminary, peer-reviewed evidence indicates that dealers and abusers have less interest in the new drugs with abuse-deterrent features.[1]  The new medications cost no more to consumers than their prior formulations. 

Several drug companies have asked the FDA for approval to bring the old, more readily abused formulations of the drugs back to the market as early as January 2013. 

"The Administration's prescription drug abuse prevention plan provides express support for abuse-deterrent medications," Barnes said.

Earlier this month, CLAAD and nine other public health and safety organizations sent a letter to the FDA urging it to implement Obama-Biden policy, foster the transition to abuse-deterrent medications, and prevent the marketing of generic versions of the drugs that do not have similar safety features.

"At today's summit, I asked General Biden to work closely with his father to make certain that the FDA does the right thing," Barnes said. 

Vice President Biden is considered one of the most accomplished national leaders in drug policy, having served as chairman of both the U.S. Senate Judiciary Committee and Drug Caucus.

"I have confidence that the Bidens will ensure that the FDA supports the shift to abuse-deterrent medications," Barnes concluded.  "We reached a turning point in our nation's prescription drug abuse epidemic at today's summit." 

[1] Cicero TJ, Ellis MS, Surratt HL. Effect of abuse-deterrent formulation of OxyContin. New England Journal of Medicine. 2012;367(2):187-189.


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GHX Reveals Roadmap to Stronger Healthcare Community at GHX Healthcare Supply Chain Summit
2. Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai
3. Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
4. Daniel Sontupe, SVP, Director of Market Access, at The CementBloc, to Present on Uncovering the Value in a Patient Support Program at CBI Summit
5. GDS Internationals Fourth Next Generation Pharmaceutical Drug Development Summit Attracts an Unprecedented Delegation of Thought Leaders
6. Cleveland Clinics 2012 Medical Innovation Summit Highlights Orthopaedic Technologies
7. Brand new Solid Form Co-Crystals and Amorphous Focus Morning at the Pharmaceutical Co-Crystals and Amorphous Material 2012 Summits
8. Online Career Service Holds Third Virtual Job Summit
9. FDAnews announces Third Annual Pharmaceutical Labeling Summit
10. VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit Meetings
11. FDAnews announces Fifth Annual Risk Management & Drug Safety Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
Breaking Medicine News(10 mins):